Literature DB >> 9802374

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis.

S Laberge1, O Ghaffar, M Boguniewicz, D M Center, D Y Leung, Q Hamid.   

Abstract

BACKGROUND: The mechanisms involved in the initiation and the maintenance of skin inflammation in atopic dermatitis (AD) are poorly understood. Previous studies have demonstrated increased numbers of infiltrating CD4+ T cells in acute lesions compared with normal control skin. IL-16 is a cytokine that has selective chemotactic activity for CD4+ cells.
OBJECTIVE: We sought to examine whether IL-16 expression might be upregulated in acute versus chronic AD.
METHODS: We investigated the expression of IL-16 mRNA in skin biopsy specimens from acute and chronic skin lesions, as well as from the uninvolved skin of patients with AD and normal skin. Cryostat sections from 4% paraformaldehyde-fixed skin biopsy specimens were processed for in situ hybridization by using cRNA coding for IL-16 mRNA. Numbers of infiltrating CD4+ and CD8+ cells were also determined by immunocytochemistry.
RESULTS: There were positive signals for IL-16 mRNA both in the basal layer of the epidermis and in the dermis of AD skin biopsy specimens from all subjects studied. The numbers of epidermal and dermal IL-16 mRNA+ cells were significantly increased in acute skin lesions compared with chronic (P <.01) and uninvolved (P <.001) skin lesions and compared with normal skin (P <.001). The number of CD4+ cells was significantly increased in acute skin lesions compared with chronic (P <.01) skin lesions and uninvolved skin (P <.01) and compared with normal skin (P <.01). Significant correlations were found between the numbers of CD4+ cells and the numbers of epidermal (r = 0.82, P <.001) and dermal (r = 0.71, P <.001) IL-16 mRNA+ cells.
CONCLUSION: The results demonstrate that upregulation of IL-16 mRNA expression in acute AD is associated with increased numbers of CD4+ cells, suggesting that IL-16 may play a role in the initiation of skin inflammation, presumably through recruitment of CD4+ cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802374     DOI: 10.1016/s0091-6749(98)70282-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

1.  Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.

Authors:  Jian C Qi; Jing Wang; Sravan Mandadi; Kumiko Tanaka; Basil D Roufogalis; Michele C Madigan; Kenneth Lai; Feng Yan; Beng H Chong; Richard L Stevens; Steven A Krilis
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

2.  The role of interleukin-16 in murine contact hypersensitivity.

Authors:  K Masuda; N Katoh; F Soga; S Kishimoto
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.

Authors:  P Middel; K Reich; F Polzien; V Blaschke; B Hemmerlein; J Herms; M Korabiowska; H J Radzun
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 4.  The allergy and immunology specialist: what is the role in the treatment of skin disease?

Authors:  Ernest N Charlesworth
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

5.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.

Authors:  Catherine A Thornton; Judith A Holloway; Janis K Shute; John W Holloway; Norma D Diaper; John O Warner
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

7.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

Authors:  Julia K Gittler; Avner Shemer; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Kara J Gulewicz; Claire Q F Wang; Hiroshi Mitsui; Irma Cardinale; Cristina de Guzman Strong; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-27       Impact factor: 10.793

8.  Integrative omics approach identifies interleukin-16 as a biomarker of emphysema.

Authors:  Russell P Bowler; Timothy M Bahr; Grant Hughes; Sharon Lutz; Yu-Il Kim; Christopher D Coldren; Nichole Reisdorph; Katerina J Kechris
Journal:  OMICS       Date:  2013-10-19

9.  The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.

Authors:  Yael Renert-Yuval; Ester Del Duca; Ana B Pavel; Milie Fang; Rachel Lefferdink; Jianni Wu; Aisleen Diaz; Yeriel D Estrada; Talia Canter; Ning Zhang; Annette Wagner; Sarah Chamlin; James G Krueger; Emma Guttman-Yassky; Amy S Paller
Journal:  J Allergy Clin Immunol       Date:  2021-01-13       Impact factor: 14.290

10.  Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?

Authors:  Pablo Ramon Gualberto Cardoso; Claudia Diniz Lopes Marques; Kamila de Melo Vilar; Andrea Tavares Dantas; Angela Luzia Branco Pinto Duarte; Ivan da Rocha Pitta; Maira Galdino da Rocha Pitta; Moacyr Jesus Barreto de Melo Rêgo
Journal:  Autoimmune Dis       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.